Soleno Therapeutics, Inc. (SLNO)
SLNO Stock Price Chart
Explore Soleno Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze SLNO price movements and trends.
SLNO Company Profile
Discover essential business fundamentals and corporate details for Soleno Therapeutics, Inc. (SLNO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Nov 2014
Employees
115.00
Website
https://soleno.lifeCEO
Anish Bhatnagar
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
SLNO Financial Timeline
Browse a chronological timeline of Soleno Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 5 Nov 2025
EPS estimate is $0.01, while revenue estimate is $46.77M.
Earnings released on 6 Aug 2025
EPS came in at -$0.09 surpassing the estimated -$0.53 by +83.02%, while revenue for the quarter reached $32.66M , missing expectations by -17.01%.
Earnings released on 7 May 2025
EPS came in at -$0.95 surpassing the estimated -$1.14 by +16.67%.
Earnings released on 27 Feb 2025
EPS came in at -$1.27 falling short of the estimated -$0.63 by -101.59%.
Earnings released on 6 Nov 2024
EPS came in at -$1.83 falling short of the estimated -$0.61 by -200.00%.
Earnings released on 7 Aug 2024
EPS came in at -$0.57 surpassing the estimated -$0.63 by +9.52%.
Earnings released on 9 May 2024
EPS came in at -$0.59 falling short of the estimated -$0.30 by -96.67%.
Earnings released on 6 Mar 2024
EPS came in at -$0.33 falling short of the estimated -$0.31 by -6.45%, while revenue for the quarter reached $3.45M .
Earnings released on 7 Nov 2023
EPS came in at -$0.95 falling short of the estimated -$0.62 by -53.23%.
Earnings released on 8 Aug 2023
EPS came in at -$0.81 falling short of the estimated -$0.70 by -15.71%.
Earnings released on 9 May 2023
EPS came in at -$0.88 falling short of the estimated -$0.71 by -23.94%.
Earnings released on 21 Mar 2023
EPS came in at -$0.58 surpassing the estimated -$0.76 by +23.68%.
Earnings released on 9 Nov 2022
EPS came in at -$0.76 surpassing the estimated -$1.05 by +27.62%.
Stock split effective on 26 Aug 2022
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 10 Aug 2022
EPS came in at -$0.90 surpassing the estimated -$1.05 by +14.29%.
Earnings released on 10 May 2022
EPS came in at -$1.05 surpassing the estimated -$1.35 by +22.22%.
Earnings released on 31 Mar 2022
EPS came in at -$1.20 matching the estimated -$1.20.
Earnings released on 10 Nov 2021
EPS came in at -$1.50 surpassing the estimated -$1.65 by +9.09%.
Earnings released on 28 Jul 2021
EPS came in at -$2.10 falling short of the estimated -$1.20 by -75.00%.
Earnings released on 5 May 2021
EPS came in at -$1.65 falling short of the estimated -$0.60 by -175.00%.
Earnings released on 3 Mar 2021
EPS came in at -$0.60 surpassing the estimated -$1.05 by +42.86%.
Earnings released on 10 Nov 2020
EPS came in at -$1.65 falling short of the estimated -$0.60 by -175.00%.
SLNO Stock Performance
Access detailed SLNO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.